Sign In
Buy OMER
$10.16
-0.1000 (-0.97%)
At Close: Jun 03, 2026
40 Stocks Moving in Tuesday's Pre-Market Session
12:31pm, Tuesday, 03'rd Mar 2020
Gainers
Superconductor Technologies Inc. (NASDAQ: SCON) shares rose 123.3% to $0.44 in pre-market trading. Superconductor Technologies and Allied Integral United announced a...
Omeros Corporation (OMER) CEO Greg Demopulos on Q4 2019 Results - Earnings Call Transcript
04:24am, Tuesday, 03'rd Mar 2020
Omeros Corporation (NASDAQ:OMER) Q4 2019 Earnings Conference Call March 2, 2020 16:30 ET CompanyParticipants Jennifer Williams - IR, Cook Williams Communication
Omeros (OMER) Reports Q4 Loss, Tops Revenue Estimates
10:35pm, Monday, 02'nd Mar 2020
Omeros (OMER) delivered earnings and revenue surprises of 36.36% and 6.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Omeros (OMER) Reports Q4 Loss, Tops Revenue Estimates
10:35pm, Monday, 02'nd Mar 2020
Omeros (OMER) delivered earnings and revenue surprises of 36.36% and 6.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
15 Stocks Moving In Monday's After-Hours Session
09:50pm, Monday, 02'nd Mar 2020
Gainers
Omeros (NASDAQ: OMER) shares are trading higher after the company reported Narsoplimab HSCT-TMA results surpassed the FDA-agreed efficacy threshold.
Fate Therapeutics...
Omeros: 4Q Earnings Snapshot
09:41pm, Monday, 02'nd Mar 2020
SEATTLE (AP) _ Omeros Corporation (OMER) on Monday reported a loss of $29.2 million in its fourth quarter. On a per-share basis, the Seattle-based company said it had a loss of 58 cents. Losses, adjus
Omeros: 4Q Earnings Snapshot
09:40pm, Monday, 02'nd Mar 2020
SEATTLE (AP) _ Omeros Corporation (OMER) on Monday reported a loss of $29.2 million in its fourth quarter. On a per-share basis, the Seattle-based company said it had a loss of 58 cents. Omeros shar
Omeros Corporation Reports Fourth Quarter and Year-End 2019 Financial Results
09:03pm, Monday, 02'nd Mar 2020
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeuti
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today reports an update on clinical data from its pivotal trial of narsoplimab in the treatment of hematopoietic stem cell transplant-associ
The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
07:52pm, Saturday, 29'th Feb 2020
Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 epidemic will likely drag global growth, the viral outbreak proved ad
Omeros (OMER) Scheduled to Post Quarterly Earnings on Monday
06:48am, Saturday, 29'th Feb 2020
Omeros (NASDAQ:OMER) is scheduled to be issuing its Q4 2019 quarterly earnings data after the market closes on Monday, March 2nd. Analysts expect the company to announce earnings of ($0.32) per share
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
